Related Experiment Videos

The glycemic index and cardiovascular disease risk

Jennie Brand-Miller1, Scott Dickinson, Alan Barclay

  • 1Human Nutrition Unit (G08), University of Sydney, Camperdown, NSW, 2006, Australia. j.brandmiller@mmb.usyd.edu.au

Current Atherosclerosis Reports
|April 2, 2008
PubMed

Insights

High blood sugar after meals (postprandial hyperglycemia) is a cardiovascular disease risk. Choosing low-glycemic index (GI) foods can improve heart health outcomes.

Area of Science:

  • Cardiovascular Science
  • Metabolic Health
  • Nutritional Science

Background:

  • Postprandial hyperglycemia is an independent risk factor for cardiovascular disease.
  • Glycemic spikes impact vascular health through oxidative stress, inflammation, and other mechanisms.
  • Carbohydrate type and quantity influence postprandial glycemic response.

Purpose of the Study:

  • To investigate the role of postprandial hyperglycemia in cardiovascular disease.
  • To evaluate the predictive value of dietary glycemic index (GI) and glycemic load (GL) for cardiovascular risk.
  • To assess the impact of low-GI diets on cardiovascular outcomes.

Main Methods:

  • Analysis of prospective observational studies correlating dietary GI/GL with cardiovascular disease risk.
  • Review of randomized controlled trials comparing low-GI carbohydrate diets with conventional low-fat diets in overweight individuals.

Main Results:

  • Dietary GI and GL independently predict cardiovascular disease risk.
  • Higher quintiles of dietary GI/GL are associated with increased cardiovascular risk (RR 1.2-1.7).
  • Low-GI diets demonstrated superior cardiovascular-related outcomes compared to conventional low-fat diets in overweight subjects.

Conclusions:

  • Postprandial hyperglycemia poses a significant cardiovascular risk.
  • Dietary GI and GL are valuable metrics for predicting cardiovascular disease.
  • Recommending low-GI/GL foods may improve cardiovascular outcomes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...